Patients and Victims

GS-II: Patients and Victims

Context

Last year, a series of reports revealed the traumatic experiences of Indian patients who had received faulty hip implants manufactured by the pharma major, Johnson and Johnson

Another investigation has revealed that Johnson and Johnson paid hefty compensations to US patients who had received the defective implants.

In India, however, the company has challenged government orders to compensate 4,700 patients who had undergone hip replacement surgeries.

Background

The investigations pertain to implants manufactured under two brand names, ASR and Pinnacle.
Both products are not in the market currently.
Johnson and Johnson recalled ASR from the global market in 2010, while Pinnacle was withdrawn in 2013.

The slow reaction by India

In India, in contrast, regulators were slow to react.
Maharashtra’s FDA red-flagged ASR a few months after Johnson and Johnson withdrew the product from the global market.
It took another year for the Central Drugs Standard Control Organisation to ban the import of ASR.
Another year went by before the drug regulator issued an advisory to orthopaedic surgeons asking them to not implant ASR.
These delays are significant because last year, Johnson and Johnson told a Union Ministry of Health and Family Welfare (MoHFW) expert committee that it cannot trace as many as 3,600 patients who underwent surgeries involving the faulty implant.
That India did not have a joint registry when these surgeries happened has compounded the problem.
The want of a registry has also come in the way of ascertaining the damage caused by Pinnacle. Johnson and Johnson claims that it has no adverse reports of the device in the country.

Conclusion

In 2017, the MoHFW issued the Medical Devices Rules. However, the country’s base legislation on implants continues to be the Drugs and Cosmetics Act, 1940, which does not have the scope to cover most modern devices, including hip implants. The Indian orthopaedic device market is valued at over 450 million dollars and is expected to grow by 30 per cent per year till 2025.The investigations into faulty hip implants bring out the urgent need for a law to regulate medical devices.

Source: Indian Express

Join Our Telegram

Sikkim from Choygal rule to Indian state

Rupee Matters

India–Azerbaijan

05 Apr, 26
SHARE

A year after tensions arising from Operation Sindoor, India and Azerbaijan have taken steps to restore and normalise bilateral relations. The 6th round of Foreign Office Consultations, held in Baku, marked the first such engagement since 2022, signaling renewed diplomatic momentum. Recent Diplomatic Engagement During the consultations, bo

India–Australia Economic Cooperation and Trade Agreem

04 Apr, 26
SHARE

The India–Australia Economic Cooperation and Trade Agreement has completed four years since its signing. Both countries now aim to build on this progress through strengthened collaboration and ambitious targets, including reaching AUD 100 billion in bilateral trade by 2030. What is the India–Australia Economic Cooperation and Tra

ADR Report on Political Funding

03 Apr, 26
SHARE

A recent report by the Association for Democratic Reforms (ADR) analyses donations of ?20,000 or more declared to the Election Commission of India (ECI) by national political parties for FY 2024–25, highlighting transparency and accountability in political financing. Key Findings Massive Funding Surge Total donations to nationa

Maritime Chokepoints

03 Apr, 26
SHARE

Maritime chokepoints are narrow channels along global shipping routes where maritime traffic is concentrated. These points are geopolitically and economically critical, as they handle a large proportion of global trade, especially energy shipments. Current Relevance Over two-thirds of seaborne energy trade passes through a handful o

US-Israel-Iran War

01 Apr, 26
SHARE

Following the launch of Operation Epic Fury (U.S.) and Operation Roaring Lion (Israel), the geopolitical landscape has shifted fundamentally with the confirmed death of Iran’s Supreme Leader, Ayatollah Ali Khamenei.Iran retaliated through Operation True Promise 4, launching missile attacks against Israel and nearby Gulf states. The escala